Raizer, Jeffrey
Northwestern University
3 papers on CoChatORCID 0009-0003-8469-2509
Most cited papers
- Verified
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Zhao, J., Chen, A. X., Gartrell, R. D., Silverman, A. M., Aparicio, L., Chu, T., Bordbar, D., Shan, D., Samanamud, J., Mahajan, A., et al. (2019) · Nature Medicine
Cancer Immunotherapy and BiomarkersGlioma Diagnosis and Treatment
Cited by 903
- Verified
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Stupp, R., Wong, E. T., Kanner, A. A., Steinberg, D., Engelhard, H., Heidecke, V., Kirson, E. D., Taillibert, S., Liebermann, F., Dbalý, V., et al. (2012) · European Journal of Cancer
Glioma Diagnosis and TreatmentElectromagnetic Fields and Biological Effects
Cited by 862
- Verified
CODEL: Phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Jaeckle, K. A., Ballman, K. V., van den Bent, M., Giannini, C., Galanis, E., Brown, P. D., Jenkins, R. B., Cairncross, J. G., Wick, W., Weller, M., et al. (2021) · Neuro-Oncology
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 119
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free